TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataIC50: 1.20E+3nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataIC50: 1.20E+3nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataIC50: 1.23E+3nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataIC50: 1.39E+3nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataIC50: 1.44E+3nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataIC50: 1.44E+3nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataIC50: 1.45E+3nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataIC50: >2.00E+3nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataIC50: >2.00E+3nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataIC50: >2.00E+3nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataIC50: >2.00E+3nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataIC50: >5.00E+3nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataIC50: >5.00E+3nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataIC50: >5.00E+3nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataIC50: >5.00E+3nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataIC50: >5.00E+3nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataIC50: >5.00E+3nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataIC50: >5.00E+3nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataIC50: >5.00E+3nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataIC50: >5.00E+3nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataIC50: >5.00E+3nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataIC50: >5.00E+3nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataIC50: >5.00E+3nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataIC50: >5.00E+3nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataIC50: >5.00E+3nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Valeant Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataIC50: >5.00E+3nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair